Cannabis Treats Brain Cancer Effectively in FDA Trial for Humans
We recently received an update on a phase 2 FDA Trial for the treatment of glioblastoma multiforme (GBM), a highly aggressive brain tumor with a limited life expectancy of approx 12 months on current therapy available. This trial was a very successful trial in light of the small sample size of 21 patients, although that is in line with international standards for this type of trial for GBM. In a randomized double blind placebo trial, 83% of the patients treated with the THC:C
